$138 Million is the total value of Birchview Capital, LP's 0 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 28.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $49,977,000 | +1997.2% | 778,585 | +1556.6% | 36.33% | +2187.7% |
| AXDX | ACCELERATE DIAGNOSTICS INC | $36,906,000 | -9.0% | 2,183,795 | 0.0% | 26.83% | -0.7% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $5,912,000 | +19.3% | 55,000 | 0.0% | 4.30% | +30.1% | |
| QDEL | QUIDEL CORP | $3,665,000 | +22.3% | 48,844 | 0.0% | 2.66% | +33.4% | |
| OXFD | OXFORD IMMUNOTEC GLOBAL PLC | $2,827,000 | -0.2% | 170,303 | 0.0% | 2.06% | +8.9% | |
| VRML | VERMILLION INC | $2,610,000 | +55.1% | 3,221,933 | 0.0% | 1.90% | +69.2% | |
| BMYRT | New | BMY CVR RTS 03/31/21right | $2,106,000 | – | 699,648 | +100.0% | 1.53% | – |
| CFRX | Buy | CONTRAFECT CORP | $1,755,000 | +2066.7% | 2,827,003 | +1145.4% | 1.28% | +2263.0% |
| EQM | Sell | EQM MIDSTRM PRTNERS LP LTDunit ltd partn | $1,536,000 | -53.6% | 51,250 | -49.4% | 1.12% | -49.4% |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $1,534,000 | +127.9% | 80,000 | +14.3% | 1.12% | +148.9% |
| SLNO | Buy | SOLENO THERAPEUTICS INC | $1,501,000 | +315.8% | 510,598 | +112.2% | 1.09% | +352.7% |
| BIIB | BIOGEN INC | $1,484,000 | +27.5% | 5,000 | 0.0% | 1.08% | +39.0% | |
| HROW | HARROW HEALTH INC | $1,400,000 | +38.3% | 180,000 | 0.0% | 1.02% | +51.0% | |
| VNDA | VANDA PHARMACEUTICALS INC | $1,313,000 | +23.6% | 80,000 | 0.0% | 0.95% | +34.7% | |
| AMRN | AMARIN CORP PLCspons adr new | $1,265,000 | +41.5% | 59,000 | 0.0% | 0.92% | +54.4% | |
| MASI | MASIMO CORP | $1,264,000 | +6.2% | 8,000 | 0.0% | 0.92% | +15.9% | |
| ARVN | ARVINAS INC | $1,233,000 | +90.6% | 30,000 | 0.0% | 0.90% | +107.9% | |
| ALBO | Buy | ALBIREO PHARMA INC | $1,220,000 | +60.5% | 48,000 | +26.3% | 0.89% | +75.3% |
| DERM | Sell | DERMIRA INC | $1,213,000 | +58.1% | 80,000 | -33.3% | 0.88% | +72.6% |
| GTHX | G1 THERAPEUTICS INC | $1,057,000 | +16.0% | 40,000 | 0.0% | 0.77% | +26.5% | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | $1,029,000 | +86.8% | 8,300 | 0.0% | 0.75% | +103.8% | |
| ARNA | ARENA PHARMACEUTICALS INC | $999,000 | -0.8% | 22,000 | 0.0% | 0.73% | +8.2% | |
| XLRN | ACCELERON PHARMA INC | $990,000 | +34.1% | 18,672 | 0.0% | 0.72% | +46.3% | |
| CCXI | New | CHEMOCENTRYX INC | $989,000 | – | 25,000 | +100.0% | 0.72% | – |
| IMGN | IMMUNOGEN INC | $919,000 | +110.8% | 180,000 | 0.0% | 0.67% | +129.6% | |
| T107PS | WRIGHT MEDICAL GROUP NV | $914,000 | +47.7% | 30,000 | 0.0% | 0.66% | +61.2% | |
| MYGN | MYRIAD GENETICS INC | $817,000 | -4.9% | 30,000 | 0.0% | 0.59% | +3.8% | |
| QGEN | New | QIAGEN NV | $676,000 | – | 20,000 | +100.0% | 0.49% | – |
| ODT | ODONATE THERAPEUTICS INC | $649,000 | +24.6% | 20,000 | 0.0% | 0.47% | +36.0% | |
| CORT | CORCEPT THERAPEUTICS INC | $605,000 | -14.4% | 50,000 | 0.0% | 0.44% | -6.6% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $599,000 | +18.8% | 14,000 | 0.0% | 0.44% | +29.5% | |
| PXD | PIONEER NATURAL RESOURCES CO | $575,000 | +20.3% | 3,800 | 0.0% | 0.42% | +31.0% | |
| BHVN | New | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $544,000 | – | 10,000 | +100.0% | 0.40% | – |
| KALV | KALVISTA PHARMACEUTICALS INC | $534,000 | +53.4% | 30,000 | 0.0% | 0.39% | +67.2% | |
| GOSS | New | GOSSAMER BIO INC | $469,000 | – | 30,000 | +100.0% | 0.34% | – |
| UTHR | New | UNITED THERAPEUTICS CORP | $440,000 | – | 5,000 | +100.0% | 0.32% | – |
| XNCR | XENCOR INC | $423,000 | +1.9% | 12,300 | 0.0% | 0.31% | +10.8% | |
| VYGR | VOYAGER THERAPEUTICS INC | $419,000 | -18.8% | 30,000 | 0.0% | 0.30% | -11.3% | |
| PGNY | New | PROGYNY INC | $412,000 | – | 15,000 | +100.0% | 0.30% | – |
| FOLD | AMICUS THERAPEUTICS INC | $370,000 | +21.3% | 38,000 | 0.0% | 0.27% | +32.5% | |
| SIEN | SIENTRA INC | $358,000 | +38.2% | 40,000 | 0.0% | 0.26% | +50.3% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $332,000 | +37.8% | 80,000 | 0.0% | 0.24% | +49.7% | |
| VCYT | Sell | VERACYTE INC | $301,000 | -20.4% | 10,767 | -31.7% | 0.22% | -13.1% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $245,000 | – | 8,000 | +100.0% | 0.18% | – |
| ECA | ENCANA CORP | $232,000 | +1.8% | 49,550 | 0.0% | 0.17% | +11.2% | |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $220,000 | -61.7% | 10,000 | -75.0% | 0.16% | -58.1% |
| CLR | Sell | CONTINENTAL RESOURCES INC | $206,000 | -16.3% | 6,000 | -25.0% | 0.15% | -8.5% |
| TGTX | TG THERAPEUTICS INC | $167,000 | +98.8% | 15,000 | 0.0% | 0.12% | +116.1% | |
| YTEN | Buy | YIELD10 BIOSCIENCE INC | $130,000 | +109.7% | 758,159 | +513.2% | 0.09% | +129.3% |
| LTHM | LIVENT CORP | $86,000 | +28.4% | 10,000 | 0.0% | 0.06% | +40.0% | |
| WKHS | WORKHORSE GROUP INC | $76,000 | -13.6% | 25,000 | 0.0% | 0.06% | -6.8% | |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $69,000 | +21.1% | 20,000 | 0.0% | 0.05% | +31.6% | |
| GNMX | Exit | AEVI GENOMIC MEDICINE INC | $0 | – | -128,000 | -100.0% | -0.01% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -10,000 | -100.0% | -0.08% | – |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -77,570 | -100.0% | -0.15% | – |
| XBIT | Exit | XBIOTECH INC | $0 | – | -30,000 | -100.0% | -0.21% | – |
| DOVA | Exit | DOVA PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.93% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -699,648 | -100.0% | -46.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.